UnitedHealth: Options Volatility Doubles Pre-Earnings 13 October Volatility

Implied volatility is running at twice realized volatility ahead of the October 13 quarterly earnings release, making options prices – the cost of insuring the underlying stock – unusually high, according to CNBC.

Implied Volatility Twice Realized Volatility Before Results

The market attributes an implied volatility of 40% to UnitedHealth Group (UNH) while realized volatility over the past eight quarters sits around 20%. This disconnect reflects anticipation of a potentially significant stock price movement around the report, a phenomenon observed during prior results when the stock fell nearly 20% in January and again in April 2025.

Options traders interpret this elevated premium as a sign of risk overvaluation, creating space for short-term selling premium strategies. The difference between implied and realized volatility opens the door to arbitrages where one sells the premium of a nearer contract (November) to fund the purchase of a longer-dated call (January) at a reduced cost.

Options Premium Arbitrage Mechanism: Sell November Premium

In practice, operators can sell the November premium, which incorporates 40% volatility, to reduce by over half the cost of a January call, whose premium incorporates anticipated volatility over a longer period. This operation generates immediate credit while maintaining a bullish exposure via the January call.

The potential gain depends on the persistence of volatility divergence; if the stock price remains stable or increases slightly after the result, the January call retains value, while the sold premium erodes, creating a net profit.

13-16% EPS Growth Targets Considered Achievable

UnitedHealth has set an EPS growth target of 13-16% for future years, an horizon that management deems realistic despite ongoing healthcare cost increases. This range is based on enrollment expansion and underwriting margin improvement.

The company notes that 90% of its 52 million global customers are based in the U.S., covering approximately 12-13.5% of the American population. Market share growth in this key segment directly supports the EPS target.

Commercial Enrollment and Medicare Growth: +2.9% and +4.5%

The commercial fee segment grew approximately 2.9% year-over-year between 2024 and 2025, while total Medicare enrollment increased 4.5% over the same period. Although the ACA market segment shows signs of slowing, it represents a smaller portion of total revenue compared to Medicare and Commercial segments.

By comparison to U.S. employment growth – estimated at 1.4% over the same period – UnitedHealth appears to gain market share, indicating its ability to attract new customers even in a modest demographic growth environment.

Valuation: 17x Forward Earnings, 5.7% Free Cash Flow of EV and 6.5% of Market Cap

The stock trades at 17 times forward earnings, a multiple that, according to CNBC, leaves little room for price appreciation. Free cash flow represents 5.7% of enterprise value (EV) and 6.5% of market cap, highlighting strong liquidity generation already factored into the current price.

These valuation metrics suggest that the market has broadly incorporated growth expectations and healthcare cost risks, limiting upside potential unless a major surprise occurs in the results.

Historical Volatility and Price Movements Around Earnings

Over the past eight quarters, UnitedHealth saw its stock price drop in five of them following earnings reports. The two most significant moves – a nearly 20% decline in January and another in April 2025 – reinforced the perception of a stock sensitive to the gap between expectations and actual performance.

This sensitivity is reflected today in elevated implied volatility, as market participants again anticipate a potential post-results correction. The current stock position, roughly 12-13% below its two-year high-low midpoint, indicates limited room for immediate rebound.

Implications for the S&P 500 and Options Strategies

UnitedHealth is a major component of the S&P 500, and its performance can influence the healthcare sector's dynamics within the index. UnitedHealth options, due to their elevated premiums, offer investors a way to benefit from volatility without directly positioning on the stock.

The selling premium strategies described earlier allow for reduced cost of bullish exposure while exploiting the disconnect between implied and realized volatility. Savvy operators will closely monitor the post-results price reaction to adjust positions accordingly.